Evidence map›Paper›PMID 31440118›Full record

ArticleJournal of machine learning research : JMLR2019

Efficient augmentation and relaxation learning for individualized treatment rules using observational data.

Ying-Qi Zhao, Eric B Laber, Yang Ning, Sumona Saha, Bruce E Sands

Abstract read
In one paragraph

Article in Journal of machine learning research : JMLR, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Fusing Individualized Treatment Rules Using Secondary Outcomes.Proceedings of machine learning research · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Discussion of Kallus (2020) and Mo et al (2020).Journal of the American Statistical Association · 2021
    Article
  18. Learning Optimal Distributionally Robust Individualized Treatment Rules.Journal of the American Statistical Association · 2021
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ying-Qi ZhaoPublic Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, 98109, USA.
Eric B LaberDepartment of Statistics, North Carolina State University, Raleigh, NC, 27695, USA.
Yang NingDepartment of Statistical Science, Cornell University, Ithaca, NY, 14853, USA.
Sumona SahaSchool of Medicine and Public Health, University of Wisconsin, Madison, WI, 53705, USA.
Bruce E SandsDivision of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.

Funding

Translational Bioimaging Core Shared ResourceP30CA015704 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI Marian Esvelt · 1985 to 2026
$296.4M
Statistical Methods for Cancer Clinical TrialsP01CA142538 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DAVIDIAN, MARIE, KOSOROK, MICHAEL R · 2010 to 2019
$21.3M
Statistical methods for healthcare in complex patients with diabetesR01DK108073 · NIDDK · FRED HUTCHINSON CANCER RESEARCH CENTER · PI ZHAO, YINGQI · 2015 to 2019
$1.5M
Supplement: Spatiotemporal models for periodontal disease monitoring and recall frequenciesR01DE024984 · NIDCR · VIRGINIA COMMONWEALTH UNIVERSITY · PI BANDYOPADHYAY, DIPANKAR, REICH, BRIAN J. · 2015 to 2017
$1.2M
FHCRC High-Performance Computing ClusterS10OD020069 · OD · FRED HUTCHINSON CANCER RESEARCH CENTER · PI KOOPERBERG, CHARLES L · 2015 to 2015
$600k
NCCDPHP CDC HHS U01 DP004785NCI NIH HHS P01 CA142538NCI NIH HHS P30 CA015704NIDCR NIH HHS R01 DE024984NIDDK NIH HHS R01 DK108073NIH HHS S10 OD020069
6 · The paper itself

Abstract

Individualized treatment rules aim to identify if, when, which, and to whom treatment should be applied. A globally aging population, rising healthcare costs, and increased access to patient-level data have created an urgent need for high-quality estimators of individualized treatment rules that can be applied to observational data. A recent and promising line of research for estimating individualized treatment rules recasts the problem of estimating an optimal treatment rule as a weighted classification problem. We consider a class of estimators for optimal treatment rules that are analogous to convex large-margin classifiers. The proposed class applies to observational data and is doubly-robust in the sense that correct specification of either a propensity or outcome model leads to consistent estimation of the optimal individualized treatment rule. Using techniques from semiparametric efficiency theory, we derive rates of convergence for the proposed estimators and use these rates to characterize the bias-variance trade-off for estimating individualized treatment rules with classification-based methods. Simulation experiments informed by these results demonstrate that it is possible to construct new estimators within the proposed framework that significantly outperform existing ones. We illustrate the proposed methods using data from a labor training program and a study of inflammatory bowel syndrome.

Indexed as

classificationconvex surrogatedouble-robustnessIndividualized treatment rulespersonalized medicine

Identifiers

PMID31440118
PMCPMC6705615

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.